- Home
- IMOS vs KOD Comparison
IMOS vs KOD Comparison
Compare IMOS & KOD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | IMOS | KOD |
|---|---|---|
| Founded | 1997 | 2009 |
| Country | Taiwan | United States |
| Employees | N/A | N/A |
| Industry | Semiconductors | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.2B | 1.3B |
| IPO Year | 2007 | 2018 |
Fundamental Metrics
Financial Performance| Metric | IMOS | KOD |
|---|---|---|
| Price | $39.82 | $24.54 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 7 |
| Target Price | N/A | ★ $28.29 |
| AVG Volume (30 Days) | 37.7K | ★ 521.8K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | ★ 1.64% | N/A |
| EPS Growth | N/A | ★ 32.60 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $20.87 | N/A |
| Revenue Next Year | $4.97 | N/A |
| P/E Ratio | $158.35 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $12.78 | $1.92 |
| 52 Week High | $45.43 | $31.18 |
Technical Indicators
Market Signals| Indicator | IMOS | KOD |
|---|---|---|
| Relative Strength Index (RSI) | 54.97 | 46.43 |
| Support Level | $16.81 | $23.92 |
| Resistance Level | $45.24 | $26.21 |
| Average True Range (ATR) | 1.73 | 1.73 |
| MACD | -0.13 | -0.17 |
| Stochastic Oscillator | 55.18 | 22.36 |
Price Performance
Historical ComparisonAbout IMOS ChipMOS TECHNOLOGIES INC.
ChipMOS TECHNOLOGIES Inc is engaged in the research, development, manufacturing, and sale of high-integration and high-precision integrated circuits and related assembly and testing services. The company's segments include Testing, Assembly, Testing, and Assembly for LCD, OLED, and other Display Panel Driver Semiconductors (LCDD), Bumping, and others. It derives a majority of its revenue from Taiwan followed by Japan, the People's Republic of China, Singapore, and others.
About KOD Kodiak Sciences Inc
Kodiak Sciences Inc is a biopharmaceutical company specializing in novel therapeutics to treat high-prevalence retinal diseases. The product candidate of the company is BLA, which is a novel antibody biopolymer conjugate, in treatment-naive subjects with neovascular wet AMD. The pipeline products of the company include Tarcocimab tedromer, KSI-501, and KSI-101.